Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-011214
Filing Date
2023-02-06
Accepted
2023-02-06 16:31:34
Documents
1
Period of Report
2023-02-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm235551-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm235551-3_4seq1.xml 4 8236
  Complete submission text file 0001104659-23-011214.txt   9798
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 910 CLOPPER ROAD, SUITE 201S GAITHERSBURG MD 20878
Business Address
Roberts M Scot (Reporting) CIK: 0001705905 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 23591121